Loading organizations...
§ Private Profile · Kanagawa Prefecture, Japan
Cellular agriculture infrastructure provider developing CulNet System for scalable cultivated meat, cosmetics, leather, and pharma.
Integriculture, based in Tokyo, Japan, develops the CulNet System, a cell culture platform for scalable production of cultivated meat, cosmetics, leather, and pharmaceuticals. This system uses "feeder" organ cells to secrete growth factors, reducing reliance on costly external additives. Its cellular agriculture infrastructure includes the CulNet Consortium, with 19 participating companies, and its Cellament cosmetic ingredient is used by over 10 companies like Euglena. The company, with 17 employees, achieved full-year profitability in 2025 and was the first globally to produce fully food-grade cell-based foods using duck liver cells in 2019. Integriculture was founded on October 23, 2015, by CEO Yuki Hanyu and CTO Ikko Kawashima, emerging from Hanyu's 2014 Shojinmeat Project. Its business model centers on revenue is split evenly between two core businesses: cellular agriculture infrastructure and cosmetics sector products. The company also operates "CulNet Pipeline" and "Ocatté Base".
Integriculture has raised $10.0M across 2 funding rounds.
Integriculture has raised $10.0M in total across 2 funding rounds.
Integriculture has raised $10.0M across 2 funding rounds. Most recently, it raised $7.0M Series A in May 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2020 | $7M Series A | — | Accomplice VC, AgFunder, Ascension Ventures, Beyond Next Ventures, First Round Capital, LAUNCH, Schematic Ventures, Season TWO Ventures, VU Venture Partners, WestWave Capital, Michael MA, ROB MAY, Future Food Fund, Iyogin Capital, Kemuri Ventures, Plan DO SEE, Real Tech Fund, Resona Capital, Sumitomo Mitsui Trust Investment, Yamaguchi Capital, Hiroshima Venture Capital, NH Foods | Announced |
| May 1, 2018 | $3M Seed | — | Beyond Next Ventures, Season TWO Ventures | Announced |
Integriculture has raised $10.0M in total across 2 funding rounds.
Integriculture's investors include Accomplice VC, AgFunder, Ascension Ventures, Beyond Next Ventures, First Round Capital, LAUNCH, Schematic Ventures, Season Two Ventures, VU Venture Partners, WestWave Capital, Michael Ma, Rob May.
IntegriCulture is a Tokyo-based cellular agriculture company that develops the patented CulNet System, a general-purpose cell culturing platform enabling scalable production of products like cultivated meat, cosmetics, leather, and pharmaceuticals without expensive external growth factors.[1][3][4] The system uses "feeder" organ cells to naturally secrete growth factors, supporting cells from any species and bypassing recombinant additives, which serves food producers, cosmetic brands, and researchers facing high costs and scalability issues in traditional cell culture.[1][6] It solves key bottlenecks in cellular agriculture—such as affordability, regulatory compliance, and versatility—while driving growth through B2B licensing, B2C products like cell-cultured foie gras (launched as the world's first legally edible version), and expansions into cosmetics (e.g., 2021 ingredient launch) and starter kits shipped overseas in 2025.[1][2][4]
IntegriCulture was founded on October 23, 2015, by Yuki Hanyu (CEO) and Ikko Kawashima (CTO) in Tokyo, Japan, emerging from Yuki's 2014 nonprofit Shojinmeat Project, an open-source initiative educating on cultured meat.[1][7] Yuki, an Oxford Ph.D. in Physical & Theoretical Chemistry focused on nanofabrication, previously researched batteries at Toshiba; the project united experts and pivoted to commercialization amid rising interest in sustainable proteins.[1] Early traction included regulatory clearance for foie gras in Japan, leadership in Japan's cellular agriculture ecosystem (founding rulemaking bodies), and pivots to derisk via diversified applications beyond meat.[1][2][6]
IntegriCulture rides the cellular agriculture wave, addressing climate change, food security, overfishing, and supply chain instability via bioreactor-grown proteins/cosmetics that cut land use and emissions vs. animal farming.[3][4] Timing aligns with Japan's regulatory progress (e.g., edible foie gras clearance) and global R&D acceleration, fueled by market forces like rising food prices, pollution-driven marine collapse, and investor interest in sustainable alt-proteins.[2][6] It influences the ecosystem by democratizing infrastructure—via open marketplaces, kits, and consortia—lowering entry barriers for startups/universities, fostering APAC leadership (e.g., Japan Association for Cellular Agriculture), and enabling cross-sector scaling.[2][4][5][7]
IntegriCulture's infrastructure-first approach positions it to dominate cellular ag enablement, with near-term milestones like advanced C-CulNet scaling, global kit expansion, and cosmetics/nutraceutical commercialization.[2][4] Trends like food-regulation pre-checks, fish-cell innovations, and pharma pivots will propel growth, evolving its role from Japan pioneer to universal platform provider amid tightening sustainability mandates.[2][4] As cellular ag matures, expect deepened B2B dominance, tying back to its mission of accessible tech that stabilizes food systems.